Is Liver Transplantation Appropriate for Patients with Potentially Resectable De Novo Hilar Cholangiocarcinoma? Discussion

被引：0
|
作者：
Martin, Robert C. G.
Nagorney, David M.
Shoup, Margo
Hemming, Alan W.
Talamonti, Mark
Chapman, William C.
机构：
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2015年 / 221卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：139 / 141
页数：4
相关论文
共 50 条
  • [31] Liver transplantation with neoadjuvant chemoradiotherapy for hilar cholangiocarcinoma.
    Rosen, CB
    Heimbach, JK
    Haddock, MG
    Alberts, SR
    Nyberg, SL
    Ishitani, MB
    Gores, GJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 436 - 436
  • [32] Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma
    Hai-Jie Hu
    Yan-Wen Jin
    Rong-Xing Zhou
    Wen-Jie Ma
    Qin Yang
    Jun-Ke Wang
    Fei Liu
    Nan-Sheng Cheng
    Fu-Yu Li
    Journal of Gastrointestinal Surgery, 2019, 23 : 510 - 517
  • [33] Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma
    Hu, Hai-Jie
    Jin, Yan-Wen
    Zhou, Rong-Xing
    Ma, Wen-Jie
    Yang, Qin
    Wang, Jun-Ke
    Liu, Fei
    Cheng, Nan-Sheng
    Li, Fu-Yu
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (03) : 510 - 517
  • [34] Transplantation Versus Resection for Hilar Cholangiocarcinoma An Argument for Shifting Treatment Paradigms for Resectable Disease
    Vibert, Eric
    Boleslawski, Emmanuel
    ANNALS OF SURGERY, 2019, 269 (01) : E5 - E6
  • [35] Risk Factors for Infections in Patients Undergoing Liver Transplantation (LT) for Hilar Cholangiocarcinoma (CCA).
    Ramanan, P.
    Cummins, N.
    Wilhelm, M.
    Heimbach, J.
    Dierkhising, R.
    Kremers, W.
    Rosen, C.
    Gores, G.
    Razonable, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 699 - 699
  • [36] Bloodstream Infections (BSI) in Patients Undergoing Liver Transplantation (LT) for Hilar Cholangiocarcinoma (CCA).
    Ramanan, P.
    Cummins, N.
    Wilhelm, M.
    Heimbach, J.
    Dierkhising, R.
    Kremers, W.
    Rosen, C.
    Gores, G.
    Razonable, R.
    TRANSPLANTATION, 2014, 98 : 698 - 698
  • [37] Risk Factors for Infections in Patients Undergoing Liver Transplantation (LT) for Hilar Cholangiocarcinoma (CCA).
    Ramanan, P.
    Cummins, N.
    Wilhelm, M.
    Heimbach, J.
    Dierkhising, R.
    Kremers, W.
    Rosen, C.
    Gores, G.
    Razonable, R.
    TRANSPLANTATION, 2014, 98 : 699 - 699
  • [38] Looking Forward: Surgical Resection, Liver Transplantation, and Hilar Cholangiocarcinoma
    Caroline C. Jadlowiec
    Julie K. Heimbach
    Current Hepatology Reports, 2016, 15 (4) : 317 - 322
  • [39] COMBINED TREATMENT OF UNRESECTABLE HILAR CHOLANGIOCARCINOMA WITH SUBSEQUENT LIVER TRANSPLANTATION
    Granov, D. A.
    Tileubergenov, I. I.
    Zhuikov, V. N.
    Sheraliev, A. R.
    Polikarpov, A. A.
    Moiseenko, A., V
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2022, 24 (01): : 7 - 14
  • [40] Outcomes of Surgical Resection versus Liver Transplantation in Hilar Cholangiocarcinoma
    White, M. K.
    Aucejo, F.
    Moro, A.
    Sasaki, K.
    Stephans, K.
    Estfan, B.
    Quintini, C.
    Eghtesad, B.
    Hashimoto, K.
    Masato, F.
    Miller, C.
    Menon, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 771 - 771
12345